Individual Patient Expanded Access-Glembatumumab Vedotin
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: Metastatic gpNMB Expressing Triple Negative Breast Cancer
Interventions: DRUG: glembatumumab vedotin
Sponsor: Celldex Therapeutics